Novo Nordisk offers to buy Belgium's Ablynx for about…


Jan 8 (Reuters) – Danish drugmaker Novo Nordisk A/S said it had made a proposal to buy Belgian biopharma firm Ablynx NV for 28.00 euro per share in cash, …

Read More…